| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/04/2010 | US20100056803 Pharmaceutically Acceptable Salts of Thymodepressin and Processes for their Manufacture |
| 03/04/2010 | US20100056802 Amorphous form of an l-arginine salt of perindopril and processes for preparation thereof |
| 03/04/2010 | US20100056799 Stable Isotope-Labeled Aromatic Amino Acids, Method for Incorporating the Same in Target Protein and Method for NMR-Structural Analysis of Proteins |
| 03/04/2010 | US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof |
| 03/04/2010 | US20100056600 11beta-hsd1 active compounds |
| 03/04/2010 | US20100056599 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids |
| 03/04/2010 | US20100056598 Cis-alkoxy-substituted spirocyclic 1h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 03/04/2010 | US20100056544 Salts with CRTH2 Antagonist Activity |
| 03/04/2010 | US20100056521 (aza)indole derivative and use thereof for medical purposes |
| 03/04/2010 | US20100051928 Organic electroluminescence device |
| 03/03/2010 | EP2159222A1 Additives to improve the electret behaviour of polycarbonates |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | CN101663272A Cbp化合物 Cbp compound |
| 03/03/2010 | CA2677563A1 Amorphous form of an l-arginine salt of perindopril and processes for preparation thereof |
| 03/02/2010 | US7671215 Process for the preparation of compounds having an ace inhibitory action |
| 03/02/2010 | US7671214 Modification of the indolium ring to permit a reactive group or conjugated substance at the 3 ring position unexpectedly mitigates the problems of quenching, difficulty in preparing, strong tendency to self-associate (stack); fluorescent dyes; biomarking; uniformity; intensity; photostability |
| 03/02/2010 | US7671117 Resin composition |
| 03/02/2010 | US7671092 Paclitaxel enhancer compounds |
| 03/02/2010 | US7671080 5-chloro-1-(2,5-dimethylbenzyl)-1H-indole-2-carboxylic acid (3-hydroxy-2,2-dimethylpropyl)amide; nicotine dependence, obesity |
| 03/02/2010 | US7671079 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 03/02/2010 | US7671075 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 02/25/2010 | WO2010021882A2 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010021878A1 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010021693A2 Mif modulators |
| 02/25/2010 | WO2010021524A2 Material for organic electronic device, and organic electronic device using the same |
| 02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
| 02/25/2010 | WO2010021129A1 Apoptosis inhibitor |
| 02/25/2010 | WO2009157015A3 Synthesis of l-(carbazol-4-yloxy)-3-[[2-(o- methoxyphenoxy)ethyl]amino]-2-propanol |
| 02/25/2010 | WO2009155001A3 Wnt protein signalling inhibitors |
| 02/25/2010 | WO2002068414A8 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/25/2010 | US20100048916 High-purity texaphyrin metal complexes |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048663 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048589 Cold Menthol Receptor Antagonists |
| 02/25/2010 | CA2733554A1 Mif modulators |
| 02/24/2010 | EP2157088A1 Indicyanine dyes and the derivatives thereof for analysing biological micromolecules |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 02/24/2010 | EP2155674A1 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| 02/24/2010 | EP1658066B9 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/24/2010 | EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 02/24/2010 | CN101657422A a transition metal catalyzed synthesis of n-aminoindoles |
| 02/24/2010 | CN101657421A methods of separation and detection of bazedoxifene acetate in pharmaceutical compositions |
| 02/24/2010 | CN101654427A Anticoagulant compound, composition and application thereof |
| 02/24/2010 | CN101654426A Method for preparing ilomastat |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/24/2010 | CN100591668C Process for the preparation of carvedilol and its enantiomers |
| 02/24/2010 | CN100591667C N-amino-1,2-cyclopentanediformylimine and preparation method thereof |
| 02/24/2010 | CN100591666C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 02/23/2010 | US7666898 Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors |
| 02/23/2010 | US7666897 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 02/23/2010 | US7666896 improved method; chemical condensation in presence of catalytic hydrogenation catalyst; hydrogenolysis; amidation; angiotensin-converting enzyme (ACE) inhibitor; hypotensive agent for treating hypertension and congestive heart failure |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/18/2010 | WO2010019828A1 Glucagon receptor antagonists |
| 02/18/2010 | WO2010019271A1 Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
| 02/18/2010 | WO2010018874A1 Amide compound |
| 02/18/2010 | WO2010018214A1 Pyrrolidinone derivatives useful for the treatement of psychotic and neurological disorders |
| 02/18/2010 | WO2010018154A1 Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof |
| 02/18/2010 | WO2010017827A1 6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases |
| 02/18/2010 | WO2009135000A3 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs |
| 02/18/2010 | US20100041866 Solid Support Reagents for Synthesis |
| 02/18/2010 | US20100041693 Indolylmaleimide derivatives |
| 02/18/2010 | US20100041674 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100041652 Tyrosine kinase inhibitors |
| 02/18/2010 | US20100041635 Oxindole compounds |
| 02/18/2010 | US20100041628 Novel indole derivative having ikappab kinase beta inhibitory activity |
| 02/18/2010 | US20100040547 Dyes and precursors and conjugates thereof |
| 02/18/2010 | DE102008041216A1 New substituted indole-carboxamide compounds useful e.g. in plant protection, for combating animal pests, arthropods, nematodes and plant diseases, and for protecting industrial materials against attack and destruction by insects |
| 02/18/2010 | CA2734322A1 Na channels, disease, and related assays and compositions |
| 02/18/2010 | CA2734225A1 Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
| 02/18/2010 | CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists |
| 02/18/2010 | CA2732095A1 Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof |
| 02/17/2010 | EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 02/17/2010 | EP1383732B1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101652346A Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents |
| 02/17/2010 | CN101648901A Method for preparing indirubin |
| 02/17/2010 | CN101648900A Production process for extracting and preparing high-purity 5-hydroxytryptophan from Griffonia simplicifolia |
| 02/17/2010 | CN101648899A New synthetic method of PET imaging agent L-5-<18>FETP |
| 02/16/2010 | US7662847 Myelodysplastic syndrome, Parkinson*s disease, multiple sclerosis, AIDS, chronic obstructive pulmonary disease, acquired respiratory distress; analgesics, angiogenesis inhibitors; anticarcinogenic and antitumor agents; phopshodiesterase, tumor necrosis factor and matrix metalloproteinase inhibitors |
| 02/16/2010 | US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 02/16/2010 | US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances |
| 02/16/2010 | CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 02/16/2010 | CA2503029C Process for synthesizing l-.gamma.-methylene glutamic acid and analogs |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | WO2010017178A1 Treatment or prevention of hepatitis c with immunomodulator compounds |
| 02/11/2010 | WO2010016612A1 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell |
| 02/11/2010 | WO2010015794A1 Novel polymorphic forms of tegaserod |
| 02/11/2010 | WO2010015745A1 Novel method for the synthesis of agomelatine |
| 02/11/2010 | WO2010015545A1 Process for the preparation of a macrocycle |
| 02/11/2010 | WO2008044243A3 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 02/11/2010 | US20100036135 Process for Making Hydroisoindoline Tachykinin Receptor Antagonists |
| 02/11/2010 | US20100035958 Novel Compounds And Compositions Thereof |
| 02/11/2010 | US20100035956 Compounds Having CRTH2 Antagonist Activity |